...
【24h】

The clinical course of peritoneal dialysis-related peritonitis caused by Corynebacterium species.

机译:棒状杆菌引起的腹膜透析相关性腹膜炎的临床过程。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Corynebacterium species are part of the normal skin flora. The incidence of nosocomial infections caused by Corynebacterium species have increased substantially over the past two decades. However, the clinical course of Corynebacterium peritonitis complicating peritoneal dialysis remains unclear. METHOD: We reviewed all the Corynebacterium peritonitis in our dialysis unit from 1995 to 2002. During this period, there were 1485 episodes of peritonitis recorded; 27 (1.8%) of which were caused by Corynebacterium species. RESULTS: The underlying renal diagnosis and prevalence of comorbid conditions of the 27 patients were similar to our whole dialysis population. The bacteria isolated were resistant to penicillin in 8 cases (29.6%). Three cases (11.1%) had concomitant exit-site infection. The overall primary response rate was 74.1%; the complete cure rate was 37.0%. Episodes that received vancomycin as initial antibiotic had a marginally higher primary response rate (9 in 10 vs 11 in 17 episodes, P = 0.2) and complete cure rates (7 in 10 vs 3 in 17 episodes, P = 0.12) than the episodes that received cephalosporins, although neither of the differences was statistically significant. Thirteen cases (48.1%) had recurrent peritonitis after antibiotic therapy, 8 of which had the recurrent episode at least 30 days after stopping antibiotics (median 54 days, range 43-60 days). Eight recurrent cases (61.5%) were successfully cured by another 3 week course of intra-peritoneal vancomycin. CONCLUSIONS: Recurrent Corynebacterium peritonitis is common after a 2 week course of antibiotics. Recurrent Corynebacterium peritonitis may be delayed up to 2 months after the antibiotic is stopped. Recurrent peritonitis can usually be cured with a 3 week course of intra-peritoneal vancomycin, which is probably the preferred antibiotic regimen for Corynebacterium peritonitis.
机译:背景:棒状杆菌属是正常皮肤菌群的一部分。在过去的二十年中,由棒杆菌属细菌引起的医院内感染的发生率已大大增加。然而,棒状杆菌腹膜炎并发腹膜透析的临床过程仍不清楚。方法:我们回顾了1995年至2002年透析部门的所有棒状杆菌腹膜炎。在此期间,记录到1485例腹膜炎发作。其中27(1.8%)是由棒状杆菌引起的。结果:27例患者的基本肾脏诊断和合并症患病率与我们整个透析人群相似。分离出的细菌对青霉素耐药8例(29.6%)。 3例(11.1%)伴有出口部位感染。总体主要缓解率为74.1%;完全治愈率为37.0%。接受万古霉素作为初始抗生素的发作,其初次反应率(10例中的9比17中的11例,P = 0.2)和完全治愈率(10例中的7与17中的3例,P = 0.12)略高。接受头孢菌素,尽管两者差异均无统计学意义。 13例(48.1%)发生抗生素治疗后复发性腹膜炎,其中8例在停止使用抗生素后至少30天复发(中位数54天,范围43-60天)。再次腹膜内万古霉素治疗3周,成功治愈了8例复发病例(61.5%)。结论:抗生素治疗2周后,复发性棒状腹膜炎很常见。停用抗生素后,复发性棒状杆菌腹膜炎可能会延迟2个月。腹膜内万古霉素通常可以在3周的疗程中治愈复发性腹膜炎,这可能是棒状杆菌腹膜炎的首选抗生素治疗方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号